Begoña Ruiz-Núñez, Rabab Tarasse, Emar F Vogelaar, D A Janneke Dijck-Brouwer, Frits A J Muskiet PMID: 29615976, PMCID: PMC5869352, DOI:10.3389/fendo.2018.00097, Front Endocrinol (Lausanne), 2018 Mar 20;9:97. doi: 10.3389/fendo.2018.00097. 2018. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869352/ ABSTRACT: Abstract Chronic fatigue syndrome (CFS) is a heterogeneous disease with unknown cause(s). CFS symptoms resemble a hypothyroid state, possibly secondary to chronic (low-grade) (metabolic) inflammation. We studied 98Continue reading “HIGHER PREVALENCE OF “LOW T3 SYNDROME” IN PATIENTS WITH CHRONIC FATIGUE SYNDROME: A CASE-CONTROL STUDY”
PFS is due to 5-alpha reductase blockade, leading to Allopregnanolone deficiency and Functional Hypothyroidism. It should be treatable.